United Therapeutics | UTHR - PE Price to Earnings

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
557.15

United Therapeutics reported 20.42 in PE Price to Earnings for its fiscal quarter ending in March of 2026.





Pe Change Date
Amarin 91.05 88.3 Jun/2023
Baxter International 86 68.9 Dec/2025
Bayer 3.4 8.75 Mar/2026
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Biogen 13.7 0.32 Mar/2026
BioMarin Pharmaceutical 15.28 3.96 Mar/2026
Emergent BioSolutions 14.4 2.25 Sep/2022
Esperion Therapeutics 129.79 129 Dec/2024
Gilead Sciences 17.7 2.07 Mar/2026
GlaxoSmithKline 14.87 3.72 Mar/2026
Halozyme Therapeutics 11.35 11.8 Mar/2026
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 24.53 0.91 Mar/2026
Lexicon Pharmaceuticals 12.44 4.73 Jun/2021
Moderna 27.22 14.51 Jun/2023
Pfizer 9.32 5.16 Mar/2026
PTC Therapeutics 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals 25.14 7.03 Mar/2026
Sarepta Therapeutics 27.27 0 Dec/2025
Teva Pharmaceutical Industries 10.07 0.04 Mar/2026
United Therapeutics 20.42 3.1 Mar/2026
Vertex Pharmaceuticals 25.82 0.33 Mar/2026